Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.
Fabienne Mackay(QIMR Berghofer Medical Research Institute), Werner Lesslauer(Roche (Switzerland))
Cited by 392
Related Papers
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7
|Proceedings of the National Academy of Sciences|2007|622
The BAFF/APRIL system in SLE pathogenesis
|Nature Reviews Rheumatology|2014|441
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
|Annals of the Rheumatic Diseases|2012|349
NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells
|Proceedings of the National Academy of Sciences|2008|103
BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
|Immunology and Cell Biology|2012|88